'VEEP' in children with Hodgkin's disease--a regimen to decrease late sequelae.

In an attempt to decrease the risk of second malignancies and future infertility in children with Hodgkin's disease (HD) while retaining acceptable remission rates, an anthracycline based regimen containing no alkylating agent has been devised. VEEP contains vincristine, epirubicin, etoposide a...

Descripción completa

Detalles Bibliográficos
Autores principales: O'Brien, M. E., Pinkerton, C. R., Kingston, J., Mott, M., Tait, D., Meller, S., Radford, M., Malpas, J., McElwain, T. J.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1992
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977393/
https://www.ncbi.nlm.nih.gov/pubmed/1586603

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977393/
https://www.ncbi.nlm.nih.gov/pubmed/1586603

Ejemplares similares